Want to know what the ACO has been up to?
The Annual Report offers highlights of ACO activities over the past fiscal year.
Read our 2015-2016 Annual Update
Advancing HIV Vaccines
Enabling productive interactions that foster new thinking and research capacity to accelerate the development of an HIV vaccine. Read more
Canadian Research that Stands Out
Facilitating an innovative and robust Canadian contribution to global HIV vaccine efforts. Read more
Building Networks Across Borders
Capitalizing on Canada’s strengths and creating new opportunities for international collaboration. Read more
Live Webcast: Professional Career Development for Trainees
The Canadian HIV Cure Enterprise (CanCURE), in partnership with the CHVI Research and Development Alliance Coordinating Office (ACO) are pleased to invite you to a live webcast entitled “Professional Career Development for trainees”. The event will be webcasted live from the Institut de recherches cliniques de Montréal (IRCM). Panelists from different sectors will present their career pathways as well as offer their perspectives and insights in order to help trainees prepare for their transition towards their area of interest following their studies.
Early- to Mid-Career level Researcher Workshop: Navigating the New HIV Funding Landscape
The Canadian Association for HIV Research (CAHR) is pleased to announce that registration is now open for the Early- to Mid-Career level HIV Researcher Workshop, which will focus on Navigating the New HIV Funding Landscape. This workshop will aim to enable researchers to succeed in the new Canadian research funding schemes, privide strategies for developing successful grant proposals, and explore research funding alternatives.
This workshop will be held in partnership with ACO, the CIHR, and Canfar.
Researcher in Focus: Felicien Moukambi
The ACO continues to feature Canadian researchers who are making an impact in HIV vaccine research and development. At the CAHR Conference held in Winnipeg, Manitoba (May 2016), HIV researcher Felicién Moukambi, talked to us about his research on the depletion of Tfh cells in SIV-infected macaques. Felicién works at the laboratory of Dr. Jérôme Estaquier at the Centre de recherche du CHU de Québec.